lifestyle
Can Ozempic Actually Cause Blood Clots? What to Know
James Madison, GLP-1 Expert
Feb 8, 2026
Ozempic is recognized for managing type 2 diabetes and supporting weight loss; however, concerns have arisen regarding its cardiovascular safety, particularly regarding blood clots. Can Ozempic cause blood clots? Insightful analysis of medical research clarifies potential risks and provides evidence-based guidance.
Individual responses to GLP-1 therapies vary, making careful monitoring vital for effective treatment management. Understanding symptom patterns and side effects can empower patients to engage in meaningful discussions with their healthcare providers. MeAgain streamlines this process with its GLP-1 app, which provides personalized tools for tracking health and medication effects.
Summary
Ozempic and semaglutide medications don't list blood clots as official side effects according to FDA prescribing information, yet a 2021 meta-analysis found a 266% increase in deep vein thrombosis among trial participants with type 2 diabetes. This statistic sounds alarming until you understand the context. The trials weren't designed to study clotting risk, and researchers couldn't determine whether the medication caused the clots or whether other factors in this patient population drove the increase. The FDA has added blood clots to its ongoing investigation into the safety of semaglutide, but definitive answers regarding causation versus correlation remain elusive.
People with type 2 diabetes face 2 to 4 times higher baseline risk for blood clots compared to those without diabetes, independent of any medication use. Patients prescribed Ozempic typically present with multiple overlapping conditions that each independently raise clotting risk, including limited mobility, obesity, high blood pressure, high cholesterol, and atherosclerosis. When someone with this complex metabolic profile develops a DVT while taking the medication, untangling whether Ozempic contributed or whether underlying conditions were responsible becomes nearly impossible. The medication occupies an uncomfortable space in which the evidence is suggestive but not definitive.
GLP-1 medications may increase the risk of clotting indirectly through their side effects rather than directly. Severe or prolonged diarrhea, one of the most common reactions to semaglutide, causes dehydration that makes blood thicker and more prone to clotting, according to the American Heart Association. Additionally, slowed gastric emptying can decrease stomach acid production and impair vitamin B12 absorption. When B12 levels drop, homocysteine levels rise, and boosted homocysteine is associated with an increased risk of clot formation. These cascading effects represent how medication affects body systems, which in turn influence coagulation.
Absolute risk is more important than relative risk percentages when evaluating personal risk. If your baseline clotting risk is 0.5%, a 266% increase brings you to approximately 1.8%, which remains low in absolute terms even though the relative increase appears dramatic. Someone with well-controlled diabetes, a healthy weight, no clotting history, and good mobility faces fundamentally different odds than someone managing multiple complications, limited movement, previous DVT, and inflammatory conditions. Applying the same percentage increase to different starting points yields markedly different absolute risks, which is why individualized medical assessment outweighs population statistics.
Weight loss achieved with Ozempic typically improves thrombotic risk profiles despite theoretical concerns regarding the medication. As body mass decreases, venous pressure decreases, inflammatory markers decline, insulin sensitivity improves, and lipid profiles normalize. The metabolic improvements that accompany meaningful weight loss often create net cardiovascular benefits that outweigh uncertain clotting risks. Patients report increased motivation to exercise as weight comes off and energy increases, creating a positive feedback loop in which medication enables weight loss, weight loss enables more movement, and movement further reduces complications through improved circulation.
GLP-1 app from MeAgain addresses this monitoring challenge by tracking hydration, protein intake, side effects such as diarrhea, and movement patterns in one place, providing visibility into the interconnected factors that influence both medication tolerance and clotting risk.
Table of Content
Can Ozempic Cause Blood Clots? (A Closer Look at the Evidence)
What are the Risk Factors and Who May Be More Vulnerable to Blood Clots?
How to Think About Risk of Blood Clots If You’re Taking Ozempic
Can Ozempic Cause Blood Clots? (A Closer Look at the Evidence)
Novo Nordisk does not list blood clots as a side effect of Ozempic, and the FDA's prescribing information also omits them. According to Jodie Pepin, Pharm.D., a clinical pharmacy program director at Harbor Health, "There is not enough evidence to say that semaglutide definitely causes blood clots." Nevertheless, the concern is not unfounded.
A 2021 meta-analysis of the SUSTAIN and PIONEER trials found that semaglutide use correlated with a 266% increase in deep vein thrombosis (DVT) among participants with Type 2 diabetes. To better manage your health alongside medications, our GLP-1 app can help track your wellness journey.
That statistic raises eyebrows; a 266% increase sounds alarming until the actual context is understood. These trials were not specifically designed to evaluate the risk of blood clots. Instead, they focused on how well semaglutide controlled blood sugar and helped with weight loss. When researchers saw a link between DVT and the medication during their analysis, they could not tell whether Ozempic caused the clots or if other factors in this specific patient group contributed to the rise.
Dr. Pepin explains that, because the trials weren't designed to detect safety signals such as clotting, "researchers did not investigate whether Ozempic caused any of the blood clots." The FDA has now added blood clots to its ongoing investigation into the safety of semaglutide, but clear answers remain difficult to obtain.
The people most likely to take Ozempic already face a higher risk of clotting before their first injection. Raj Singh, MD, a primary care provider at HEALOR, calls diabetes "a mother of all diseases" because it rarely exists alone. Patients usually deal with multiple overlapping problems: limited mobility, a higher chance of infections, heart failure, chronic kidney disease, and lung issues. Each of these increases the risk of clotting independently.
When you add obesity, high blood pressure, high LDL cholesterol, and atherosclerosis, you see a health profile that makes blood clots more likely, no matter the medication used.
Is it hard to determine the cause of DVT?
When someone with this health profile gets a DVT while taking Ozempic, figuring out what caused it can be really hard. The medication may be a factor, or the existing health issues may be the cause. Both things might work together in ways we don't completely get.
One person who had a clotting event while using a GLP-1 medication described the mental burden well: "I can't shake the correlation out of my mind." This confusion creates real stress, especially since the same medication can have important benefits, such as reduced inflammation, improved insulin sensitivity, and significant weight loss.
Could diarrhea increase clotting risk?
Even if Ozempic doesn't directly cause blood clots, its side effects may increase the risk. Diarrhea is one of the most common stomach reactions to semaglutide. When severe or long-lasting, it can lead to dehydration. Dehydrated blood becomes thicker and stickier.
According to the American Heart Association, this increases the likelihood of blood clot formation. This isn't a direct effect of the medicine; it's a chain reaction. The drug causes changes in digestion. These changes cause fluid loss, which alters blood flow.
Dr. Singh notes another possible reason: reduced stomach acid production. GLP-1 medications slow gastric emptying, which can reduce acid production and make it harder to absorb nutrients. This can lead to lower vitamin B12 levels.
When B12 levels drop, homocysteine levels can go up. High homocysteine levels are associated with an increased risk of blood clots. Again, this isn't Ozempic directly causing clots; rather, it's the medication altering digestion, affecting nutrient absorption, influencing amino acid processing, and possibly altering blood clotting.
How can patients track their treatment?
When managing GLP-1 treatment, tracking interconnected factors is essential. Hydration status and digestive symptoms are essential. Protein intake significantly affects how full you feel and your nutritional needs.
Tools like MeAgain help you monitor your water intake, log side effects like diarrhea, and track your protein consumption all in one place. Instead of wondering whether you're drinking enough or guessing at patterns, you can see data that helps you stay proactive and share specific observations with your healthcare provider. This visibility changes vague worry into an informed conversation.
What is the current understanding of the risks?
The gap between clinical trial findings and real-world prescribing creates confusion. Many patients report that their physicians approved GLP-1 use while on anticoagulants such as Eliquis without hesitation. One person shared that their doctor "didn't flinch" when discussing the combination.
Another noted that their neurologist and hematologist "have no issues" with continuing semaglutide therapy despite a previous clotting event. These experiences clash with the 266% DVT increase reported in the meta-analysis, leaving patients caught between alarming statistics and reassuring medical guidance.
The truth is that this story is unfolding in real time. GLP-1 medications are relatively new at scale, and long-term safety data are still being gathered. The FDA's investigation will eventually provide clearer answers; however, doctors are currently making risk-benefit calculations based on incomplete information.
For individuals with PCOS, hypothyroidism, insulin resistance, and obesity, the metabolic benefits of semaglutide may outweigh the uncertain clotting risk, especially when paired with anticoagulation therapy and careful monitoring.
On the other hand, for someone with different risk factors, the calculations might lead to a different conclusion.
What is the honest assessment of the situation?
Dr. Pepin's assessment provides the most candid summary: the concerns raised by the meta-analysis prompted a desire for further study. Until these studies conclude, patients and doctors navigate uncertainty together.
The medication has not been shown to be dangerous, nor has it been shown to be safe with respect to clotting. It exists in an uncomfortable space where evidence is suggestive but not definitive, with clear correlation but unclear causation.
Understanding your personal risk factors significantly changes how you deal with that uncertainty.
Related Reading
What are the Risk Factors and Who May Be More Vulnerable to Blood Clots?
Your baseline risk matters more than the medication itself. Type 2 diabetes changes blood chemistry in ways that prepare your body for clotting. Hyperglycemia harms the delicate lining of blood vessels, making them more reactive.
As platelets become stickier, coagulation factors increase, while your body's natural mechanisms for breaking down clots weaken. If your HbA1c stays above the target range, your risk for blood clots goes up higher than that of someone who keeps tight control of their blood sugar.
Obesity makes this problem worse on its own. Excess weight increases venous pressure, induces chronic low-grade inflammation, and alters coagulation factors toward a prothrombotic state. According to research from the CDC, almost 1 in 4 people worldwide die from problems caused by blood clots.
When you add inactivity to obesity and diabetes, the risk increases even more. Sitting for long periods slows blood flow in leg veins, and that stillness can lead to thrombosis, especially in the deep veins of the calf and thigh. To help manage these risks, consider our GLP-1 app that supports weight management and promotes healthier lifestyle choices.
How do previous clot events influence future risks?
Previous clotting events predict future occurrences with uncomfortable accuracy. If someone has experienced a DVT or pulmonary embolism, their risk of recurrence sits substantially higher than that of a person without such a history. This prior experience significantly affects how any new medicine is evaluated. Family history also plays an important role.
Inherited thrombophilias, such as Factor V Leiden or prothrombin gene mutations, can be inherited. This creates a genetic predisposition that exists regardless of lifestyle choices. These factors cannot be changed through diet or exercise; they are genetic.
What role does age play in blood clot risk?
Age is an important factor in the risk of blood clots. As people age, their vascular health deteriorates. The walls of blood vessels lose flexibility, and blood circulation becomes less effective. The same body that moves easily at 30 requires more deliberate effort at 60.
When someone has several overlapping risk factors—like diabetes, obesity, being over 50, and having a previous clot history—the risk assessment changes. It focuses less on any one medication and more on managing a complex set of health issues, making thrombotic events more likely.
How does active cancer affect clotting risk?
Active cancer significantly increases the risk of thrombosis in several ways. Malignant cells release substances that promote clotting, and chemotherapy can harm blood vessels. This combination leads to a hypercoagulable state, where clots are more likely to form. Recent surgery or injury also adds to this risk.
When tissue is damaged, inflammatory responses are activated to stop bleeding; however, these same processes can also promote harmful clot formation. Orthopedic surgeries, particularly hip and knee replacements, carry a particularly high risk of thromboembolism during recovery.
What hormonal factors should be considered?
Hormone-based medications add extra challenges. Both estrogen-containing contraceptives and hormone replacement therapy can raise the risk of clotting. When managing diabetes and considering GLP-1 therapy, the hormonal component must be included in the overall risk assessment.
Smoking accelerates atherosclerosis, damages endothelial cells, and increases blood viscosity. Inflammatory bowel disease causes long-term inflammation that hurts vascular health. While each factor by itself might seem manageable, together they create a risk profile that needs careful attention.
How can monitoring improve risk management?
When managing many variables, visibility becomes an important protective factor. While one cannot control genetic factors or alter past clotting events, it is possible to track modifiable factors that influence daily risk. For example, how much water you drink affects blood viscosity, while adequate protein supports blood vessel health and preserves muscle mass, both of which are important for circulation. Also, how often you move affects whether blood collects in the legs or continues to flow well.
Tools such as MeAgain help track water intake and protein goals and monitor side effects, such as diarrhea, that may indicate dehydration. Instead of guessing whether they are managing these factors, people can observe the patterns that emerge. This information facilitates better conversations with healthcare teams about what is actually happening in the body, rather than relying on fear or guesswork.
What should women of childbearing potential know?
Women who can have children should consider several factors. Semaglutide is not recommended for use during pregnancy or breastfeeding. The product information states clearly that you need effective contraception while taking the medication and should stop taking it at least two months before you try to get pregnant. This timeline is not random. It shows how long the medication stays in your system and makes sure you're not exposing a developing baby during those important early weeks when you might not know that you're pregnant yet.
What are the implications of hormonal contraception while on Ozempic?
This requirement connects awkwardly with talks about hormonal contraception. If a woman is using estrogen-based birth control to prevent pregnancy while on Ozempic, she is adding a known thrombotic risk factor to her concerns about reproductive safety. The situation becomes quite complex.
Some women choose non-hormonal contraception methods, while others accept the added risk with proper monitoring. There is no single right answer; instead, decisions should be personal and made with a complete understanding of the trade-offs involved.
What precautions are advised during long-haul flights?
Long-haul flights create a temporary but significant increase in risk. Staying seated for extended periods in tight airline seats reduces blood flow to the legs. Changes in cabin pressure and dehydration from recirculated air exacerbate these problems.
For most people, standard preventive measures are sufficient: walking up and down the aisle every few hours, drinking plenty of water, and wearing compression stockings. These simple actions help maintain blood flow and reduce the risk of stagnation.
When is pharmacological thromboprophylaxis necessary?
Pharmacological thromboprophylaxis with anticoagulant injections is reserved for very high-risk individuals. If someone has a recent clot history, active cancer, or multiple risk factors, a doctor may prescribe prophylactic anticoagulation for the journey.
This decision requires clinical assessment rather than relying on Internet advice.
The threshold for intervention depends on how specific risk factors combine and interact; it is not based on a one-size-fits-all protocol.
What symptoms should high-risk patients recognize?
Patients with significant risk factors benefit from symptom education no matter what medication they use. It's important to recognize deep vein thrombosis (DVT) and pulmonary embolism for early detection. Symptoms such as swelling in one leg, warmth, redness, and calf pain may indicate a DVT.
On the other hand, sudden shortness of breath, chest pain that gets worse with deep breathing, fast heart rate, or coughing up blood can be signs of a pulmonary embolism. These symptoms require immediate medical evaluation; you should not wait to see if they resolve.
How often should high-risk patients be monitored?
More frequent monitoring of high-risk patients reflects good standards of diabetes care rather than specific precautions associated with Ozempic. If a doctor suggests visits every three months instead of every six months, that choice is based on overall metabolic complexity, not worries about the medication itself.
The cardiovascular benefits proven in clinical trials, like reduced heart attack and stroke risk (reduced heart attack and stroke risk), improved glycemic control, and meaningful weight loss, usually outweigh any theoretical thrombotic concerns for most patients. The key term here is theoretical; the current understanding is based on proposed connections rather than established cause-and-effect relationships.
What does the meta-analysis data mean for personal risk?
However, many overlook a crucial point when discussing the 266% increase reported in the meta-analysis: understanding personal risk factors can substantially affect how one interprets that number.
Related Reading
How to Think About Risk of Blood Clots If You’re Taking Ozempic
Your personal risk factors matter more than population statistics. When looking at blood clot concerns, the focus should not be on whether semaglutide might raise DVT risk across thousands of trial participants.
Instead, the key question is whether your health profile, combined with this medication, creates a real risk worth worrying about. This different question requires you to consider your individual situation rather than focusing on general percentages that may not apply to you.
People with type 2 diabetes are 2-4 times more likely to develop blood clots compared to those without diabetes. This higher risk is present even before considering GLP-1 therapy. A 266% increase in DVT in clinical trials indicates a risk calculation within a high-risk group. If your initial risk was 0.5%, a 266% increase would bring it to approximately 1.8%. Although this may seem low, the relative increase is substantial.
The math changes a lot if your baseline risk is different. For example, someone with well-controlled diabetes, a healthy weight, no clotting history, and good movement has different odds than someone dealing with several complications, limited mobility, previous DVT, and inflammatory issues.
The same percentage increase across different starting points yields very different absolute risks. This underscores why your doctor's view of your situation is more important than general trial data from people who may share only a diabetes diagnosis with you.
What should you do about panic Googling?
Panic Googling after noticing leg swelling rarely yields productive results. Instead, it often results in alarming statistics, conflicting stories, and worst-case scenarios that increase anxiety without giving personalized clarity. The real danger is not the symptom itself, but the paralysis that results from attempting to self-diagnose through online research rather than obtaining a professional evaluation.
Unilateral leg swelling, especially when accompanied by warmth and tenderness, requires same-day medical assessment, not a Reddit thread discussing others' similar experiences. Likewise, sudden shortness of breath combined with chest pain needs immediate emergency care, rather than scrolling through forum posts to decide whether it might be anxiety. In these cases, crowdsourced experiences do not provide clarity. Instead, clinical judgment, diagnostic tools, and your complete medical history determine the right course of action.
How can you address escalating worry?
Many people experience a pattern of escalating worry. They notice a symptom, search for information, find concerning possibilities, and obsessively monitor for other signs. This often spirals into anxiety that can feel worse than the original concern.
One individual managing multiple risk factors effectively captured the mental burden. The uncertainty about whether each new sensation signifies danger creates a constant background stress that undermines the quality of life improvements the medication was supposed to provide.
To break this cycle, seeking professional consultation is essential. Your doctor can evaluate whether your experiences warrant further investigation or if they represent normal variation that doesn't require intervention.
What are simple strategies to reduce risk?
Staying hydrated helps with both GLP-1 side effects and clotting risk. When diarrhea occurs as a side effect, you lose fluids quickly, which makes your blood thicker and disrupts electrolyte balance. Drinking enough water during the day helps maintain blood flow, reducing the risk of clots, and also helps your digestive system process the medication's effects more effectively.
Movement is just as important. Sitting for too long allows blood to pool in the leg veins, which makes it easier for clots to form. This is an issue for everyone, whether they are using Ozempic or not, but it is especially important for people dealing with diabetes and weight loss at the same time.
Regular movement throughout the day, not just during exercise, keeps blood flowing. Standing every hour, walking during phone calls, and stretching between tasks may seem small, but these actions help maintain blood flow and prevent stagnation.
The challenge isn't knowing these tips, but actually doing them regularly. Managing medication side effects, tracking health metrics, and building lasting habits can be challenging. Remembering to drink enough water seems easy until nausea makes drinking hard, or when focusing on protein intake causes hydration to be forgotten.
Tracking these basic habits, along with other health information, provides a clearer picture that helps translate plans into action. Keeping a record of your water intake can reveal patterns, such as drinking less on busy days or a link between digestive problems and lower hydration. This provides helpful insights into where to focus your efforts rather than merely feeling guilty about not drinking enough.
How does diet influence wellness?
A healthy diet rich in vegetables, fruits, whole grains, and adequate protein supports more than just weight loss. It provides important fiber to help manage gastrointestinal issues associated with semaglutide and nutrients that support heart health. This balanced diet helps you feel full, making the medication easier to handle.
However, foods high in sugar and fat can make stomach side effects worse, leading to a miserable experience that makes it hard to stick with the treatment.
The dietary plan that reduces the risk of blood clots, including balanced nutrition, enough hydration, and regular protein intake, strongly aligns with the eating habits that support GLP-1 therapy.
Why are check-ups important for your health?
Regular check-ups with a healthcare provider create a monitoring framework that catches problems early. Doctors track blood pressure, cholesterol, kidney function, and glycemic control.
These metrics are important not only for managing diabetes; they also serve as cardiovascular risk indicators that can better predict thrombotic events than any single medication. When these numbers improve, and they usually do with effective GLP-1 therapy, your overall clotting risk often decreases, even with any theoretical medication concerns.
Should you consider vitamin B12 supplementation?
Vitamin B12 supplementation deserves consideration if digestive changes may impair absorption. Low B12 levels can raise homocysteine, which correlates with an increased clotting tendency.
While this isn't a proven prevention strategy, it addresses a plausible mechanism with minimal downside. However, this logic does not extend to reducing medication dosage. There is no evidence that lower doses of semaglutide reduce the risk of thrombosis. In fact, reducing your dose might compromise the metabolic benefits that lower cardiovascular risk.
What happens as you lose weight on Ozempic?
As you lose weight with Ozempic, your thrombotic risk profile usually improves. Losing weight reduces mechanical pressure on veins, thereby lowering inflammatory markers.
Insulin sensitivity also improves, and blood fat levels tend to normalize. The metabolic improvements that accompany significant weight loss often outweigh the potential risks of the medication, making it a net benefit even if some clotting concerns remain.
How does exercise relate to medication effects?
People often feel more motivated to exercise as they lose weight and their energy levels go up. This increased activity reduces the risk of clotting by improving circulation and reducing time spent sitting.
The positive feedback loop, medicine helps with weight loss, weight loss leads to more movement, and movement helps reduce problems, shows a real-life result that population-level statistics do not capture.
Individual experiences with the medication can differ substantially from those of the average trial participant because personal responses, adherence, and incorporation into daily life all affect outcomes.
What tools can help track your progress?
Tools like MeAgain help track the connected factors that determine whether someone is building positive momentum or experiencing side effects that slow their progress. By keeping an eye on protein intake, water consumption, movement patterns, and digestive symptoms all in one place, people can see how these things work together. For example, a person might notice that reaching their protein goal is associated with fewer cravings and greater energy for walking.
Additionally, drinking enough water may reduce gastrointestinal side effects that were originally attributed solely to the medication. These insights transform vague prevention advice into personalized strategies grounded in empirical patterns.
How to communicate effectively with your doctor?
The most valuable conversation you can have about clotting risk is with someone who knows your full medical history, current medications, family history, and lifestyle. This person can evaluate whether your specific risk profile requires additional monitoring, whether any symptoms warrant further investigation, and whether the medication's benefits justify continued use despite potential concerns. Internet research cannot provide a personalized evaluation because it lacks the context to make the assessment meaningful.
According to research on GLP-1 receptor agonists, patients may have a 2- to 3-fold higher risk of blood clots in some studies. Your doctor interprets what this means for you based on factors that no online calculator or forum discussion can assess.
If you have several risk factors, your doctor's advice may change. If your diabetes complications are getting worse despite other treatments, the heart benefits might clearly outweigh clotting concerns. The assessment is personal, not universal.
What observations should you share with your doctor?
Bringing specific observations to appointments makes them more productive. For example, saying, "I've noticed leg swelling in the evenings" gives your doctor something concrete to evaluate. In contrast, saying, "I'm concerned about blood clots because I read about them online" initiates a conversation focused on abstract concerns rather than real symptoms. When you regularly track patterns like hydration, movement, side effects, and symptoms, you come in with information that helps create a helpful discussion rather than vague anxiety, which is harder to address directly.
Understanding these prevention tactics is only useful if they can be applied consistently in daily life.
Related Reading
Top Semaglutide Providers
Best Place To Get Mounjaro
Best Place To Buy Tirzepatide Online
Best Place To Get Wegovy Online
Stay Informed About Your GLP-1 Journey With MeAgain
Staying aware of how your body responds to GLP-1 therapy matters more than worrying about every statistic. The difference between being carefully observant and being overly anxious lies in tracking real patterns rather than chasing imagined worries.
When you regularly monitor your hydration, protein intake, side effects, and physical changes, you create a record that helps both you and your healthcare provider make decisions based on your reality, not on general averages that may not apply to your situation.
MeAgain provides a single place to capture what's actually happening during treatment. Instead of depending on scattered notes about water intake, unclear memories of when side effects started, or guessing whether you're meeting protein goals, you can see clear patterns that help you have meaningful conversations with your doctor.
This clarity transforms uncertainty into understanding, empowering you to be proactive about your health while building the healthy habits that are important for long-term success with GLP-1 therapy. Every journey is different, and tracking yours provides context that transforms worry into informed awareness.